RIVASTIGMINE 4.5 MG CAPSULE

Rivastigmine Tartrate
$0.2100per EA

Strength

4.5 mg/1

NDC

62332006560

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

RIVASTIGMINE TARTRATE

Approval Type

Generic (ANDA)

FDA Application

ANDA091689

On Market Since

6/12/2022

Pharmacological Classes

Cholinesterase Inhibitor
Cholinesterase Inhibitors

Price History

1W

0.0%

1M

+5.9%

3M

+5.9%

6M

+12.2%

1Y

-3.2%

3Y

+3.6%

5Y

N/A

All

+4.7%